This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 May;16(5):758-9.

doi: 10.1093/neuonc/nou054. Epub 2014 Apr 10.

Heat shock protein peptide complex-96 (HSPPC-96) vaccination for recurrent glioblastoma: a phase II, single arm trial

Orin Bloch¹, Andrew T Parsa

Affiliations

PMID: 24729070
PMCID: PMC3984567
DOI: 10.1093/neuonc/nou054

Comment

Heat shock protein peptide complex-96 (HSPPC-96) vaccination for recurrent glioblastoma: a phase II, single arm trial

Orin Bloch et al. Neuro Oncol. 2014 May.

. 2014 May;16(5):758-9.

doi: 10.1093/neuonc/nou054. Epub 2014 Apr 10.

Authors

Orin Bloch¹, Andrew T Parsa

Affiliation

¹ Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

PMID: 24729070
PMCID: PMC3984567
DOI: 10.1093/neuonc/nou054

No abstract available

PubMed Disclaimer

Comment on

Is there a role for vaccine-based therapy in recurrent glioblastoma?
Chamberlain MC. Chamberlain MC. Neuro Oncol. 2014 May;16(5):757. doi: 10.1093/neuonc/nou031. Neuro Oncol. 2014. PMID: 24733854 Free PMC article. No abstract available.

Similar articles

Editorial on "heat shock protein peptide complex-96 (HSPPC-96) vaccination for recurrent glioblastoma: a phase II, single arm trial".
Sampson JH, Vlahovic G. Sampson JH, et al. Neuro Oncol. 2014 Jan;16(2):169-70. doi: 10.1093/neuonc/not311. Neuro Oncol. 2014. PMID: 24443362 Free PMC article. No abstract available.
Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial.
Bloch O, Crane CA, Fuks Y, Kaur R, Aghi MK, Berger MS, Butowski NA, Chang SM, Clarke JL, McDermott MW, Prados MD, Sloan AE, Bruce JN, Parsa AT. Bloch O, et al. Neuro Oncol. 2014 Jan;16(2):274-9. doi: 10.1093/neuonc/not203. Epub 2013 Dec 12. Neuro Oncol. 2014. PMID: 24335700 Free PMC article. Clinical Trial.
Is there a role for vaccine-based therapy in recurrent glioblastoma?
Chamberlain MC. Chamberlain MC. Neuro Oncol. 2014 May;16(5):757. doi: 10.1093/neuonc/nou031. Neuro Oncol. 2014. PMID: 24733854 Free PMC article. No abstract available.
Heat-shock proteins-based immunotherapy for advanced melanoma in the era of target therapies and immunomodulating agents.
Tosti G, Cocorocchio E, Pennacchioli E, Ferrucci PF, Testori A, Martinoli C. Tosti G, et al. Expert Opin Biol Ther. 2014 Jul;14(7):955-67. doi: 10.1517/14712598.2014.902928. Epub 2014 Mar 26. Expert Opin Biol Ther. 2014. PMID: 24670226 Review.
Heat shock proteins in glioblastomas.
Yang I, Fang S, Parsa AT. Yang I, et al. Neurosurg Clin N Am. 2010 Jan;21(1):111-23. doi: 10.1016/j.nec.2009.09.002. Neurosurg Clin N Am. 2010. PMID: 19944971 Review.

See all similar articles

Cited by

Relapsed Glioblastoma: Treatment Strategies for Initial and Subsequent Recurrences.
Tosoni A, Franceschi E, Poggi R, Brandes AA. Tosoni A, et al. Curr Treat Options Oncol. 2016 Sep;17(9):49. doi: 10.1007/s11864-016-0422-4. Curr Treat Options Oncol. 2016. PMID: 27461038 Review.
The future of high-grade glioma: Where we are and where are we going.
Le Rhun E, Rhun EL, Taillibert S, Chamberlain MC. Le Rhun E, et al. Surg Neurol Int. 2015 Feb 13;6(Suppl 1):S9-S44. doi: 10.4103/2152-7806.151331. eCollection 2015. Surg Neurol Int. 2015. PMID: 25722939 Free PMC article.
Blockade of Na/H exchanger stimulates glioma tumor immunogenicity and enhances combinatorial TMZ and anti-PD-1 therapy.
Guan X, Hasan MN, Begum G, Kohanbash G, Carney KE, Pigott VM, Persson AI, Castro MG, Jia W, Sun D. Guan X, et al. Cell Death Dis. 2018 Sep 27;9(10):1010. doi: 10.1038/s41419-018-1062-3. Cell Death Dis. 2018. PMID: 30262908 Free PMC article.
Optimizing glioblastoma resection: intraoperative mapping and beyond.
Osorio JA, Aghi MK. Osorio JA, et al. CNS Oncol. 2014;3(5):359-66. doi: 10.2217/cns.14.36. CNS Oncol. 2014. PMID: 25363008 Free PMC article. Review.
Heat shock protein vaccines against glioblastoma: from bench to bedside.
Ampie L, Choy W, Lamano JB, Fakurnejad S, Bloch O, Parsa AT. Ampie L, et al. J Neurooncol. 2015 Jul;123(3):441-8. doi: 10.1007/s11060-015-1837-7. Epub 2015 Jun 21. J Neurooncol. 2015. PMID: 26093618 Free PMC article. Review.

See all "Cited by" articles

References

1. Bloch O, Han SJ, Cha S, et al. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article. J Neurosurg. 2012;117:1032–1038. - PubMed
1. Lacroix M, Abi-Said D, Fourney DR, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001;95:190–198. - PubMed
1. McGirt MJ, Chaichana KL, Gathinji M, et al. Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg. 2009;110:156–162. - PubMed
1. Chamberlain MC. Convection-enhanced delivery of a transforming growth factor-beta2 inhibitor trabedersen for recurrent high-grade gliomas: efficacy real or imagined?, in reference to Bogdahn et al. (Neuro-Oncology 2011;13:132-142) Neuro Oncol. 2011;13:558–559. author reply 561-552. - PMC - PubMed
1. Chamberlain MC. Treatment of glioblastoma with bevacizumab: has a new standard therapy been defined? CNS Drugs. 2011;25:815–818. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- MedlinePlus Health Information